ATE318818T1 - Annellierte azepinone als inhibitoren cyclin- abhängiger kinasen - Google Patents

Annellierte azepinone als inhibitoren cyclin- abhängiger kinasen

Info

Publication number
ATE318818T1
ATE318818T1 AT99928715T AT99928715T ATE318818T1 AT E318818 T1 ATE318818 T1 AT E318818T1 AT 99928715 T AT99928715 T AT 99928715T AT 99928715 T AT99928715 T AT 99928715T AT E318818 T1 ATE318818 T1 AT E318818T1
Authority
AT
Austria
Prior art keywords
aliphatic
alcohols
substituents
particularly alkyl
hydrogen
Prior art date
Application number
AT99928715T
Other languages
German (de)
English (en)
Inventor
Conrad Kunick
Laurent Meijer
Daniel W Zaharevitz
Rick Gussio
Ravi K Jalluri
Edward A Sausville
Original Assignee
Us Gov Health & Human Serv
Conrad Kunick
Laurent Meijer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv, Conrad Kunick, Laurent Meijer filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE318818T1 publication Critical patent/ATE318818T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT99928715T 1998-06-16 1999-06-16 Annellierte azepinone als inhibitoren cyclin- abhängiger kinasen ATE318818T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8961998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
ATE318818T1 true ATE318818T1 (de) 2006-03-15

Family

ID=22218651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99928715T ATE318818T1 (de) 1998-06-16 1999-06-16 Annellierte azepinone als inhibitoren cyclin- abhängiger kinasen

Country Status (8)

Country Link
US (1) US6610684B2 (https=)
EP (1) EP1086105B1 (https=)
JP (1) JP4555476B2 (https=)
AT (1) ATE318818T1 (https=)
AU (1) AU778735B2 (https=)
CA (1) CA2335115C (https=)
DE (1) DE69930120T2 (https=)
WO (1) WO1999065910A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804959B1 (fr) * 2000-02-15 2006-04-28 Centre Nat Rech Scient Utilisation de derives de paullones pour la fabrication de medicaments
JP4527404B2 (ja) 2002-04-04 2010-08-18 エンゾン，インコーポレーテッド インドールのポリマー性アシル誘導体
DE10260618B4 (de) * 2002-12-23 2005-06-09 Faustus Forschungs Cie. Translational Cancer Research Gmbh Tumorhemmende annellierte Azepinonderivate
PL1748691T3 (pl) * 2004-05-12 2011-04-29 Bayer Cropscience Ag Sposób regulacji wzrostu roślin
WO2006089874A1 (en) * 2005-02-22 2006-08-31 Gpc Biotech Ag Benzo[2,3]azepino[4,5-b]indol-6-ones
EP1757607A1 (en) 2005-08-24 2007-02-28 Molisa GmbH N5-substituted benzo¬2,3|azepino¬4,5-b|indol-6-ones for treating tropical diseases
FR2899107B1 (fr) * 2006-03-30 2008-06-13 Neurokin Entpr Unipersonnelle Utilisation de la (s)-roscovitine pour la fabrication d'un medicament
WO2009010298A2 (en) * 2007-07-18 2009-01-22 Technische Universität Carolo-Wilhelmina Zu Braunschweig Paullone derivatives and its use
US8716308B2 (en) 2008-01-11 2014-05-06 Albany Molecular Research, Inc. (1-azinone)-substituted pyridoindoles
JP2012504646A (ja) * 2008-10-01 2012-02-23 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 選択的サイクリン依存性キナーゼ４／６阻害剤を用いた化学療法化合物に対する造血系の防護
CN102231983A (zh) * 2008-10-01 2011-11-02 北卡罗来纳大学查珀尔希尔分校 使用选择性细胞周期蛋白依赖性激酶4/6抑制剂对抗电离辐射的造血防护
EP2414358A1 (en) * 2009-03-31 2012-02-08 ArQule, Inc. Substituted tetrahydropyrazolo-pyrido-azepin compounds
EP3406260B1 (en) 2009-05-13 2020-09-23 The University of North Carolina at Chapel Hill Cyclin dependent kinase inhibitors and methods of use
WO2011003012A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US8637501B2 (en) * 2009-07-01 2014-01-28 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof
US9073925B2 (en) * 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8629158B2 (en) * 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
KR20120060201A (ko) 2009-07-08 2012-06-11 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 기능적으로 분화된 체세포의 연장된 자기재생을 유도하는 방법
WO2011112635A1 (en) 2010-03-08 2011-09-15 Sloan-Kettering Institute For Cancer Research Cdc7 kinase inhibitors and uses thereof
EP2640394A4 (en) 2010-11-17 2015-02-25 Univ North Carolina PROTECTION OF KIDNEY TISSUE FROM ISCHEMIA BY THE INHIBITION OF PROLEVERATIVE KINASES CDK4 AND CDK6
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
HK1222766A1 (zh) 2013-03-15 2017-07-14 G1治疗公司 高效的抗赘生剂和抗增生剂
DK2968290T3 (da) 2013-03-15 2019-11-25 G1 Therapeutics Inc Transient beskyttelse af normale celler under kemoterapi
WO2015161285A1 (en) 2014-04-17 2015-10-22 G1 Therapeutics, Inc. Tricyclic lactams for use in the protection of hematopoietic stem and progenitor cells against ionizing radiation
WO2016040858A1 (en) 2014-09-12 2016-03-17 G1 Therapeutics, Inc. Combinations and dosing regimes to treat rb-positive tumors
WO2016040848A1 (en) 2014-09-12 2016-03-17 G1 Therapeutics, Inc. Treatment of rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors
EA201891170A1 (ru) 2015-11-18 2018-11-30 Джензим Корпорейшн Биомаркер поликистозной болезни почек и варианты его применения
US10988479B1 (en) 2020-06-15 2021-04-27 G1 Therapeutics, Inc. Morphic forms of trilaciclib and methods of manufacture thereof
WO2022104206A1 (en) * 2020-11-13 2022-05-19 Neuron23, Inc. Kinase modulators and methods of use thereof
EP4277897A1 (en) * 2021-01-12 2023-11-22 Chengdu Anticancer Bioscience, Ltd. Fused azepine compounds and their use in the treatment of cancer
US12258345B1 (en) 2023-12-12 2025-03-25 King Faisal University Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642779A (en) * 1969-10-22 1972-02-15 Robins Co Inc A H Indolo(1 2-d)(1 4)benzodiazepin-6-ones
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
ATE239020T1 (de) * 1996-10-09 2003-05-15 Schering Corp Tricyclische verbindungen als ras-fpt inhibitoren

Also Published As

Publication number Publication date
EP1086105A1 (en) 2001-03-28
CA2335115C (en) 2009-01-27
CA2335115A1 (en) 1999-12-23
DE69930120D1 (de) 2006-04-27
US20020042412A1 (en) 2002-04-11
AU4571499A (en) 2000-01-05
EP1086105B1 (en) 2006-03-01
US6610684B2 (en) 2003-08-26
JP4555476B2 (ja) 2010-09-29
WO1999065910A9 (en) 2000-03-16
JP2002518395A (ja) 2002-06-25
DE69930120T2 (de) 2006-11-02
WO1999065910A1 (en) 1999-12-23
AU778735B2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
ATE318818T1 (de) Annellierte azepinone als inhibitoren cyclin- abhängiger kinasen
EP0143746A3 (de) Substituierte 5-Amino-4-hydroxyvalerylderivate
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
UA41875C2 (uk) Спосіб інгібування естрогензалежних пухлин з використанням стероїдних сульфатовмісних інгібіторів
DE69826847D1 (de) Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
PT783490E (pt) Compostos de 1-acil-4-alifatilaminopiperidina
MX9604420A (es) Derivados de pirimidinilo como inhibidores de la interleucina.
DK1007039T3 (da) Hidtil ukendte heterocykliske analoger til diphenylethylenforbindelser
PE20011096A1 (es) COMPUESTOS DE PIRROLO[2,3-d]PIRIMIDINA COMO INHIBIDORES DE QUINASAS
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
ES425897A1 (es) Procedimiento para la obtencion de esteres de acidos fosfo-ricos.
ES2015011B3 (es) Esteres de acido acrilico sustituido y fungicidas que contienen estos compuestos.
ES2032596T3 (es) Composiciones inhibidoras de corrosion.
ATE271614T1 (de) Quinone-derivate zur verbesserung der zellulare bioenergie
ES8606394A1 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
CS621987A2 (en) Coating composition
ATE19251T1 (de) Hemmer der kollagenase der saeugetiere.
PE20040768A1 (es) Derivados de arilen-(2-amino-fenil)-carboxamida como inhibidores de la histona desacetilasa (hdac)
ATE181731T1 (de) Isothioharnstoff-derivate als no synthase hemmer
ES397786A1 (es) Procedimiento para la obtencion de derivados piperidinicos.
ATE37360T1 (de) Ester von imidazolaethanol.
EP0144290A3 (de) Substituierte Aethylendiaminderivate
AR018632A1 (es) Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion.
BE827081A (fr) Compositions de fluides fonctionnels renfermant des composes monoepoxycyclohexyliques comme produits de balayage d'acides et inhibiteurs de corrosion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties